Functional assays demonstrated a decrease in self-renewal capacity in endothelial cells co-cultured with GBM cells when treated with GANT61 and GLI1 disruption (Figure 4E-F and Figure S5A-B). The gene discussed is GLI1; the disease is glioblastoma.